Trusted News Discovery Since 2008
{{/content}}
AstraZeneca admits its COVID-19 vaccine Covishield can cause rare...
Credit: DNA- Published 2 weeks ago
Covishield was developed by AstraZeneca in collaboration with the Oxford University during the COVID-19 pandemic
Video credit: Rumble
Published 2 weeks ago - 06:02
Political uproar in India after Astrazeneca admits blood clot side effect
A political controversy has erupted in India after British pharma giant Astrazeneca admitted in the UK court that it's Covid-19 vaccine to blood clots in "very rare cases". The company's statement came after 51 lawsuits accused the vaccine of being "defective" and leading to serious injury and death. Watch in for more details!
You are here
Related videos from verified sources
AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court 05:11
Credit: Oneindia - Published 1 week ago
Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia 03:03
Credit: Oneindia - Published 2 weeks ago